ロード中...
mTOR inhibitor INK128 promotes wound healing by regulating MDSCs
BACKGROUND: Skin wounds in diabetic patients hardly recover. Accumulating evidence has shown that mammalian target of rapamycin (mTOR) pathway and myeloid-derived suppressor cells (MDSCs) are involved in inflammatory-related response. INK128 is a novel mTOR kinase inhibitor in clinical development....
保存先:
| 出版年: | Stem Cell Res Ther |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7944919/ https://ncbi.nlm.nih.gov/pubmed/33691762 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-021-02206-y |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|